The biology of lantibiotics from the lacticin 481 group is coming of age

FEMS Microbiology Reviews

Volumn 31, Issue 2, 2007, Pages 134-167

  Dufour, Alain ^a   Hindré, Thomas ^a,b   Haras, Dominique ^a   Le Pennec, Jean Paul ^a  

^a UNIVERSITÉ DE BRETAGNE SUD   (France)

^b CEMAGREF   (France)

Author keywords

Lacticin 481; Lantibiotic; Mutacin II; Nukacin ISK 1; Salivaricin; Streptococcin A FF22

Indexed keywords

BACTERIOCIN; BUTYRIVIBRIOCIN; CYTOLYSIN; LACTICIN; LANTHIONINE; LANTIBIOTIC; MACEDOCIN; MERSACIDIN; MUTACIN 2; NUKACIN; OROTIC ACID; RUMINOCOCCIN A; SALIVARICIN A; SALIVARICIN B; STEPTOCOCCIN; UNCLASSIFIED DRUG; VARIACIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; ENZYME MODIFICATION; FOOD INDUSTRY; GENE CLUSTER; GENE LOCATION; GENE SEGREGATION; GENETIC CONSERVATION; GENETIC LINKAGE; GRAM POSITIVE BACTERIUM; IMMUNITY; LACTIC ACID BACTERIUM; MICROFLORA; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; QUORUM SENSING; REVIEW; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

POSIBACTERIA;

EID: 33846863326     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2006.00045.x     Document Type: Review

References (261)

1. Akçelik O, Tükel Ç , Özcengiz & Akçelik M (2006) Characterization of bacteriocins from two Lactococcus lactis subsp. lactis isolates. Mol Nutr Food Res 50: 306-313.
2. Altena K, Guder A, Cramer C & Bierbaum G (2000) Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster. Appl Environ Microbiol 66: 2565-2571.
3. Arqúes JL, Rodríguez E, Gaya P, Medina M, Guamis B & Nuñez M (2005a) Inactivation of Staphylococcus aureus in raw milk cheese by combinations of high-pressure treatments and bacteriocin-producing lactic acid bacteria. J Appl Microbiol 98: 254-260.
4. Arqúes JL, Rodríguez E, Gaya P, Medina M & Nuñez M (2005b) Effect of combinations of high-pressure treatment and bacteriocin-producing lactic acid bacteria on the survival of Listeria monocytogenes in raw milk cheese. Int Dairy J 15: 893-900.
5. Asaduzzaman SM, Nagao J, Aso Y, Nakayama J & Sonomoto K (2006) Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1. Appl Environ Microbiol 72: 6012-6017.
6. Aso Y, Nagao J, Koga H, Okuda K, Kanemasa Y, Sashihara T, Nakayama J & Sonomoto K (2004a) Heterologous expression and functional analysis of the gene cluster for the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1. J Biosci Bioeng 98: 429-436.
7. Aso Y, Sashihara T, Nagao J et al. (2004b) Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1. Biosci Biotechnol Biochem 68: 1663-1671.
8. Aso Y, Koga H, Sashihara T, Nagao J, Kanemasa Y, Nakayama J & Sonomoto K (2005a) Description of complete DNA sequence of two plasmids from the nukacin ISK-1 producer, Staphylococcus warneri ISK-1. Plasmid 53: 164-178.
9. Aso Y, Okuda K, Nagao J, Kanemasa Y, Phuong NTB, Koga H, Shioya K, Sashihara T, Nakayama J & Sonomoto K (2005b) A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. Biosci Biotechnol Biochem 69: 1403-1410.
10. Augustin J, Rosenstein R, Wieland B, Schneider U, Schnell N, Engelke G, Entian KD & Götz F (1992) Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur J Biochem 204: 1149-1154.
11. Ávila M, Garde S, Gaya P, Medina M & Nuñez M (2005a) Influence of a bacteriocin-producing lactic culture on proteolysis and texture of Hispánico cheese. Int Dairy J 15: 145-153.
12. Ávila M, Garde S, Medina M & Nuñez M (2005b) Effect of milk inoculation with bacteriocin-producing lactic acid bacteria on a Lactobacillus helveticus adjunct cheese culture. J Food Prot 68: 1026-1033.
13. Ávila M, Garde S, Ferńandez-García E, Medina M & Nuñez M (2006) Effect of high-pressure treatment and a bacteriocin-producing lactic culture on the odor and aroma of Hispánico cheese: correlation of volatile compounds and sensory analysis. J Agric Food Chem 54: 382-389.
14. Banerjee S & Hansen JN (1988) Structure and expression of a gene encoding the precursor of subtilin, a small protein antibiotic. J Biol Chem 263: 9508-9514.
15. Bierbaum G, Reis M, Szekat C & Sahl HG (1994) Construction of an expression system for engineering of the lantibiotic Pep5. Appl Environ Microbiol 60: 4332-4338.
16. Bierbaum G, Brötz H, Koller KP & Sahl HG (1995) Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol Lett 127: 121-126.
17. Bierbaum G, Götz F, Peschel A, Kupke T, van de Kamp M & Sahl HG (1996a) The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Antonie Leeuwenhoek 69: 119-127.
18. Bierbaum G, Szekat C, Josten M, Heidrich C, Kempter C, Jung G & Sahl H-G (1996b) Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl Environ Microbiol 62: 385-392.
19. Bonelli RR, Schneider T, Sahl HG & Wiedemann I (2006) Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob Agents Chemother 50: 1449-1457.
20. Bongers RS, Veening JW, Van Wieringen M, Kuipers OP & Kleerebezem M (2005) Development and characterization of a subtilin-regulated expression system in Bacillus subtilis: strict control of gene expression by addition of subtilin. Appl Environ Microbiol 71: 8818-8824.
21. Booth MC, Bogie CP, Sahl HG, Siezen RJ, Hatter KL & Gilmore MS (1996) Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol Microbiol 21: 1175-1184.
22. Brötz H, Bierbaum G, Markus A, Molitor E & Sahl HG (1995) Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob Agents Chemother 39: 714-719.
23. Brötz H, Bierbaum G, Reynolds PE & Sahl HG (1997) The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur J Biochem 246: 193-199.
24. Brötz H, Bierbaum G, Leopold K, Reynolds PE & Sahl HG (1998a) The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother 42: 154-160.
25. Brötz H, Josten M, Wiedemann I, Schneider U, Götz F, Bierbaum G & Sahl HG (1998b) Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol 30: 317-327.
26. Breukink E (2006) A lesson in efficient killing from two-component lantibiotics. Mol Microbiol 61: 271-273.
27. Breukink E & de Kruijff B (2006) Lipid II as a target for antibiotics. Nat Rev Drug Discov 5: 321-332.
28. Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl HG & de Kruijff B (1999) Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286: 2361-2364.
29. Breukink E, van Heusden HE, Vollmerhaus PJ, Swiezewska E, Brunner S, Heck AJ & de Kruijff B (2003) Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J Biol Chem 278: 19898-19903.
30. Buchman GW, Banerjee S & Hansen JN (1988) Structure, expression, and evolution of a gene encoding the precursor of nisin, a small protein antibiotic. J Biol Chem 263: 16260-16266.
31. Burton JP, Chilcott CN & Tagg JR (2005) The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis 11: 29-31.
32. Burton JP, Chilcott CN, Moore CJ, Speiser G & Tagg JR (2006a) A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 100: 754-764.
33. Burton JP, Wescombe PA, Moore CJ, Chilcott CN & Tagg JR (2006b) Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol 72: 3050-3053.
34. Centeno JA, Gaya P, Medina M & Nuñez M (2002) Cross-inhibition among wild strains of Lactococcus lactis isolated from the same ecological niche. J Food Prot 65: 205-210.
35. Chan WC, Leyland M, Clark J, Dodd HM, Lian LY, Gasson MJ, Bycroft BW & Roberts GCK (1996) Structure-activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin. FEBS Lett 390: 129-132.
36. Chandrapati S & O'Sullivan DJ (2002) Characterization of the promoter regions involved in galactose- and nisin-mediated induction of the nisA gene in Lactococcus lactis ATCC 11454. Mol Microbiol 46: 467-477.
37. Chatterjee C, Miller LM, Leung YL, Xie L, Yi M, Kelleher NL & van der Donk WA (2005a) Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production. J Am Chem Soc 127: 15332-15333.
38. Chatterjee C, Paul M, Xie L & van der Donk WA (2005b) Biosynthesis and mode of action of lantibiotics. Chem Rev 105: 633-683.
39. Chaussee MS, Somerville GA, Reitzer L & Musser JM (2003) Rgg coordinates virulence factor synthesis and metabolism in Streptococcus pyogenes. J Bacteriol 185: 6016-6024.
40. Chen P, Novak J, Kirk M, Barnes S, Qi F & Caufield PW (1998a) Structure-activity study of the lantibiotic mutacin II from Streptococcus mutans T8 by a gene replacement strategy. Appl Environ Microbiol 64: 2335-2340.
41. Chen P, Novak J, Qi F & Caufield PW (1998b) Diacylglycerol kinase is involved in regulation of expression of the lantibiotic mutacin II of Streptococcus mutans. J Bacteriol 180: 167-170.
42. Chen P, Qi F, Novak J & Caufield PW (1999) The specific genes for lantibiotic mutacin II biosynthesis in Streptococcus mutans T8 are clustered and can be transferred en bloc. Appl Environ Microbiol 65: 1356-1360.
43. Chen P, Qi F, Novak J, Krull RE & Caufield PW (2001) Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II. FEMS Microbiol Lett 195: 139-144.
44. Chikindas ML, Novák J, Driessen AJM, Konings WN, Schilling KM & Caufield PW (1995) Mutacin II, a bactericidal lantibiotic from Streptococcus mutans. Antimicrob Agents Chemother 39: 2656-2660.
45. Choung SY, Kobayashi T, Inoue J, Takemoto K, Ishitsuka H & Inoue K (1988) Hemolytic activity of a cyclic peptide Ro09-0198 isolated from Streptoverticillium. Biochim Biophys Acta 940: 171-179.
46. Coburn PS & Gilmore MS (2003) The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell Microbiol 5: 661-669.
47. Coburn PS, Hancock LE, Booth MC & Gilmore MS (1999) A novel means of self-protection, unrelated to toxin activation, confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin. Infect Immun 67: 3339-3347.
48. Coburn PS, Pillar CM, Jett BD, Haas W & Gilmore MS (2004) Enterococcus faecalis senses target cells and in response expresses cytolysin. Science 306: 2270-2272.
49. Corvey C, Stein T, Düsterhus S, Karas M & Entian KD (2003) Activation of subtilin precursors by Bacillus subtilis extracellular serine proteases subtilisin (AprE), WprA, and Vpr. Biochem Biophys Res Commun 304: 48-54.
50. Cotter PD, Hill C & Ross RP (2005a) Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Protein Pept Sci 6: 61-75.
51. Cotter PD, Hill C & Ross RP (2005b) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3: 777-788.
52. Cotter PD, O'Connor PM, Draper LA, Lawton EM, Deegan LH, Hill C & Ross RP (2005c) Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc Natl Acad Sci USA 102: 18584-18589.
53. Cotter PD, Hill C & Ross RP (2006) What's in a name? Class distinction for bacteriocins. Nat Rev Microbiol 4: 2. doi:10.1038/nrmicro1273-c2.
54. Czárán TL, Hoeskstra RF & Pagie L (2002) Chemical warfare between microbes promotes biodiversity. Proc Natl Acad Sci USA 99: 786-790.
55. Dabard J, Bridonneau C, Philippe C et al. (2001) Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol 67: 4111-4118.
56. Delves-Broughton J, Blackburn P, Evans RJ & Hugenholtz J (1996) Applications of the bacteriocin, nisin. Antonie Leeuwenhoek 69: 193-202.
57. Demel RA, Peelen T, Siezen RJ, de Kruijff B & Kuipers OP (1996) Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity. A monolayer study. Eur J Biochem 235: 267-274.
58. de Ruyter PGGA, Kuipers OP & de Vos WM (1996) Controlled gene expression systems for Lactococcus lactis using the foodgrade inducer nisin. Appl Environ Microbiol 62: 3662-3667.
59. de Vos WM, Kuipers OP, van der Meer JR & Siezen RJ (1995) Maturation pathway of nisin and other lantibiotics: posttranslationally modified antimicrobial peptides exported by Gram-positive bacteria. Mol Microbiol 17: 427-437.
60. Dodd HM, Horn N & Gasson MJ (1990) Analysis of the genetic determinant for production of the peptide antibiotic nisin. J Gen Microbiol 136: 555-566.
61. Dougherty BA, Hill C, Weidman JF, Richardson DR, Venter JC & Ross RP (1998) Sequence and analysis of the 60 kb conjugative, bacteriocin-producing plasmid pMRC01 from Lactococcus lactis DPC3147. Mol Microbiol 29: 1029-1038.
62. Drider D, Fimland G, Héchard Y, McMullen LM & Prévost H (2006) The continuing story of class IIa bacteriocins. Microbiol Mol Biol Rev 70: 564-582.
63. Dufour A, Thuault D, Boulliou A, Bourgeois CM & Le Pennec J-P (1991) Plasmid-encoded determinants for bacteriocin production and immunity in a Lactococcus lactis strain and purification of the inhibitory peptide. J Gen Microbiol 137: 2423-2429.
64. Dufour A, Rincé A, Uguen P & Le Pennec J-P (2000) IS1675, a novel lactococcal insertion element, forms a transposon-like structure including the lacticin 481 lantibiotic operon. J Bacteriol 182: 5600-5605.
65. Dufour A, Rincé A, Hindré T, Haras H & Le Pennec J-P (2003) Lacticin 481: an antimicrobial peptide of the lantibiotic family produced by Lactococcus lactis. Recent Res Devel Bacteriol 1: 219-234.
66. Eijsink VGH, Axelsson L, Diep DB, Håvarstein LS, Holo H & Nes IF (2002) Production of class II bacteriocins by lactic acid bacteria; an example of biological warfare and communication. Antonie Leeuwenhoek 81: 639-654.
67. Engelke G, Gutowski-Eckel Z, Hammelmann M & Entian KD (1992) Biosynthesis of the lantibiotic nisin: genomic organization and membrane localization of the NisB protein. Appl Environ Microbiol 58: 3730-3743.
68. Engelke G, Gutowski-Eckel Z, Kiesau P, Siegers K, Hammelmann M & Entian KD (1994) Regulation of nisin biosynthesis and immunity in Lactococcus lactis 6F3. Appl Environ Microbiol 60: 814-825.
69. Entian KD & de Vos WM (1996) Genetics of subtilin and nisin biosyntheses. Antonie Leeuwenhoek 69: 109-117.
70. Franke CM, Tiemersma J, Venema G & Kok J (1999) Membrane topology of the lactococcal bacteriocin ATP-binding cassette transporter protein LcnC. J Biol Chem 274: 8484-8490.
71. 2, and structural revision of duramycin and cinnamycin. Nisin and Novel Lantibiotics (Jung G & Sahl H-G, eds), pp. 131-140. ESCOM, Leiden.
72. Garde S, Rodríguez E, Gaya P, Medina M & Nuñez M (2001) PCR detection of the structural genes of nisin Z and lacticin 481 in Lactococcus lactis subsp. lactis INIA 415, a strain isolated from raw milk Manchego cheese. Biotechnol Lett 23: 85-89.
73. Garde S, Carbonell M, Fernández-García E, Medina M & Nuñez M (2002a) Volatile compounds in Hispánico cheese manufactured using a mesophilic starter, a thermophilic starter, and bacteriocin-producing Lactococcus lactis subsp. lactis INIA 415. J Agric Food Chem 50: 6752-6757.
74. Garde S, Tomillo J, Gaya P, Medina M & Nuñez M (2002b) Proteolysis in Hispánico cheese manufactured using a mesophilic starter, a thermophilic starter, and bacteriocin-producing Lactococcus lactis subsp. lactis INIA 415 adjunct culture. J Agric Food Chem 50: 3479-3485.
75. Garde S, Ávila M, Gaya P, Medina M & Nuñez M (2006) Proteolysis of Hispánico cheese manufactured using lacticin 481-producing Lactococcus lactis subsp. lactis INIA 639. J Dairy Sci 89: 840-849.
76. Georgalaki MD, Van den Berghe E, Kritikos D, Devreese B, Van Beeumen J, Kalantzopoulos G, De Vuyst L & Tsakalidou E (2002) Macedocin, a food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198. Appl Environ Microbiol 68: 5891-5903.
77. Georgalaki M, Aktypis A, Manolopoulou E, Gavriil A & Tsakalidou E (2005) Induction of macedocin biosynthesis, a lantibiotic produced by Streptococcus macedonicus ACA-DC 198. 8th FEMS Symposium on Lactic Acid Bacteria. Genetics, Metabolism and Applications. Egmond aan Zee, The Netherlands.
78. Georgalaki M, Anastasiou R, Papadelli M, Devreese B, Van Driessche G, Van Beeumen J & Tsakalidou E (2006) Induction of bacteriocin production in Streptococcus macedonicus ACA-DC 198. 1st International Symposium on Food, Veterinary and Medical Applications of Antimicrobial Peptides. Nantes, France.
79. Gillor O, Kirkup BC & Riley MA (2004) Colicins and microcins: the next generation antimicrobials. Adv Appl Microbiol 54: 129-146.
80. Gilmore MS, Segarra RA & Booth MC (1990) An HlyB-type function is required for expression of the Enterococcus faecalis hemolysin/ bacteriocin. Infect Immun 58: 3914-3923.
81. Gilmore MS, Segarra RA, Booth MC, Bogie CP, Hall LR & Clewell DB (1994) Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants. J Bacteriol 176: 7335-7344.
82. Gilmore MS, Skaugen SK & Nes I (1996) Enterococcus faecalis cytolysin and lactocin S of Lactobacillus sake. Antonie Leeuwenhoek 69: 129-138.
83. Gomez A, Laridé M, Marcille F & Fons M (2002) Trypsin mediates growth phase-dependent transcriptional regulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota. J Bacteriol 184: 18-28.
84. Gross E & Kiltz HH (1973) The number and nature of α, β-unsaturated amino acids in subtilin. Biochem Biophys Res Commun 50: 559-565.
85. Gross E & Morell JL (1971) The structure of nisin. J Am Chem Soc 93: 4634-4635.
86. Guder A, Wiedemann I & Sahl HG (2000) Posttranslationally modified bacteriocins-the lantibiotics. Biopolymers 55: 62-73.
87. Guder A, Schmitter T, Wiedemann I, Sahl HG & Bierbaum G (2002) Role of the single regulator MrsR1 and the two-component system MrsR2/K2 in the regulation of mersacidin production and immunity. Appl Environ Microbiol 68: 106-113.
88. Guinane CM, Cotter PD, Hill C & Ross RP (2005) Microbial solutions to microbial problems; lactococcal bacteriocins for the control of undesirable biota in food. J Appl Microbiol 98: 1316-1325.
89. Gutowski-Eckel Z, Klein C, Siegers K, Bohm K, Hammelmann M & Entian KD (1994) Growth phase-dependent regulation and membrane localization of SpaB, a protein involved in biosynthesis of the lantibiotic subtilin. Appl Environ Microbiol 60: 1-11.
90. Haas W, Shepard BD & Gilmore MS (2002) Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction. Nature 415: 84-87.
91. Hasper HE, de Kruijff B & Breukink E (2004) Assembly and stability of nisin-lipid II pores. Biochemistry 43: 11567-11575.
92. Håvarstein LS, Holo H & Nes IF (1994) The leader peptide of colicin V shares consensus sequences with leader peptides that are common among peptide bacteriocins produced by Gram-positive bacteria. Microbiology 140: 2383-2389.
93. Håvarstein LS, Diep DB & Nes IF (1995) A family of bacteriocin ABC transporters carry out proteolytic processing of their substrate concomitant with export. Mol Microbiol 16: 229-240.
94. Héchard Y & Sahl HG (2002) Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie 84: 545-557.
95. Heidrich C, Pag U, Josten M, Metzger JW, Jack RW, Bierbaum G, Jung G & Sahl HG (1998) Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol 64: 3140-3146.
96. Heng NCK & Tagg JR (2006) What's in a name? Class distinction for bacteriocins. Nat Rev Microbiol 4: 2. doi:10.1038/nrmicro1273-c1.
97. Hille M, Kies S, Götz F & Peschel A (2001) Dual role of GdmH in producer immunity and secretion of the staphylococcal lantibiotics gallidermin and epidermin. Appl Environ Microbiol 67: 1380-1383.
98. Hindré T, Didelot S, Le Pennec J-P, Haras D, Dufour A & Vallée-Réhel K (2003) Bacteriocin detection from whole bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol 69: 1051-1058.
99. Hindré T, Le Pennec J-P, Haras D & Dufour A (2004) Regulation of lantibiotic lacticin 481 production at the transcriptional level by acid pH. FEMS Microbiol Lett 231: 291-298.
100. Hoffmann A, Schneider T, Pag U & Sahl HG (2004) Localization and functional analysis of PepI, the immunity peptide of Pep5-producing Staphylococcus epidermidis strain 5. Appl Environ Microbiol 70: 3263-3271.
101. Hsu ST, Breukink E, Bierbaum G, Sahl HG, de Kruijff B, Kaptein R, van Nuland NA & Bonvin AM (2003) NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity. J Biol Chem 278: 13110-13117.
102. Hsu ST, Breukink E, Tischenko E, Lutters MA, de Kruijff B, Kaptein R, Bonvin AM & van Nuland NA (2004) The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol 11: 963-967.
103. Huot E, Meghrous J, Barrena-Gonzalez C & Petitdemange H (1996) Bacteriocin J46, a new bacteriocin produced by Lactococcus lactis subsp. cremoris J46: isolation and characterization of the protein and its gene. Anaerobe 2: 137-145.
104. Hynes WL & Ferretti JJ (1995) A response regulator gene controls production of the lantibiotic streptococcin A-FF22. Dev Biol Stand 85: 635-637.
105. Hynes WL, Ferretti JJ & Tagg JR (1993) Cloning of the gene encoding streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence. Appl Environ Microbiol 59: 1969-1971.
106. Hynes WL, Friend VL & Ferretti JJ (1994) Duplication of the lantibiotic structural gene in M-type 49 group A Streptococcus strains producing streptococcin A-M49. Appl Environ Microbiol 60: 4207-4209.
107. Ike Y, Clewell DB, Segarra RA & Gilmore MS (1990) Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn917 insertional mutagenesis and cloning. J Bacteriol 172: 155-163.
108. Jack R, Benz R, Tagg J & Sahl H-G (1994a) The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur J Biochem 219: 699-705.
109. Jack RW, Carne A, Metzger J, Stefanović S, Sahl H-G, Jung G & Tagg J (1994b) Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22. Eur J Biochem 220: 455-462.
110. Jack RW, Tagg JR & Ray B (1995) Bacteriocins of Gram-positive bacteria. Microbiol Rev 59: 171-200.
111. Jung G (1991) Lantibiotics: a survey. Nisin and Novel Lantibiotics (Jung G & Sahl H-G, eds), pp. 1-34. ESCOM, Leiden.
112. Kaletta C & Entian KD (1989) Nisin, a peptide antibiotic: cloning and sequencing of the nisA gene and posttranslational processing of its peptide product. J Bacteriol 171: 1597-1601.
113. Kaletta C, Entian KD, Kellner R, Jung G, Reis M & Sahl HG (1989) Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol 152: 16-19.
114. Kaletta C, Entian KD & Jung G (1991) Prepeptide sequence of cinnamycin (Ro09-0198): the first structural gene of a duramycin-type lantibiotic. Eur J Biochem 199: 411-415.
115. Kalmokoff ML, Lu D, Whitford MF & Teather RM (1999) Evidence for production of a new lantibiotic (butyrivibriocin OR79A) by the ruminal anaerobe Butyrivibrio fibrisolvens OR79: characterization of the structural gene encoding butyrivibriocin OR79A. Appl Environ Microbiol 65: 2128-2135.
116. Karakas Sen A, Narbad A, Horn N, Dodd HM, Parr AJ, Colquhoun I & Gasson MJ (1999) Post-translational modification of nisin. The involvement of NisB in the dehydration process. Eur J Biochem 261: 524-532.
117. Kies S, Vuong C, Hille M, Peschel A, Meyer C, Götz F & Otto M (2003) Control of antimicrobial peptide synthesis by the agr quorum sensing system in Staphylococcus epidermidis: activity of the lantibiotic epidermin is regulated at the level of precursor peptide processing. Peptides 24: 329-338.
118. Kiesau P, Eikmanns U, Gutowski-Eckel Z, Weber S, Hammelmann M & Entian KD (1997) Evidence for a multimeric subtilin synthetase complex. J Bacteriol 179: 1475-1481.
119. Kimura H, Nagano R, Matsusaki H, Sonomoto K & Ishizaki A (1997) A bacteriocin of strain Pediococcus sp. ISK-1 isolated from Nukadoko, bed of fermented rice bran. Biosci Biotech Biochem 61: 1049-1051.
120. Kimura H, Matsusaki H, Sashihara T, Sonomoto K & Ishizaki A (1998) Purification and partial identification of bacteriocin ISK-1, a new lantibiotic produced by Pediococcus sp. ISK-1. Biosci Biotechnol Biochem 62: 2341-2345.
121. Klaenhammer TR (1988) Bacteriocins of lactic acid bacteria. Biochimie 70: 337-349.
122. Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12: 39-86.
123. Kleerebezem M (2004) Quorum sensing control of lantibiotic production; nisin and subtilin autoregulate their own biosynthesis. Peptides 25: 1405-1414.
124. Kleerebezem M & Quadri LE (2001) Peptide pheromone-dependent regulation of antimicrobial peptide production in Gram-positive bacteria: a case of multicellular behaviour. Peptides 22: 1579-1596.
125. Kleerebezem M, Beerthuyzen MM, Vaughan EE, de Vos WM & Kuipers OP (1997) Controlled gene expression systems for lactic acid bacteria: transferable nisin-inducible expression cassettes for Lactococcus, Leuconostoc and Lactobacillus ssp. Appl Environ Microbiol 63: 4581-4584.
126. Klein C & Entian KD (1994) Genes involved in self-protection against the lantibiotic subtilin produced by Bacillus subtilis ATCC 6633. Appl Environ Microbiol 60: 2793-2801.
127. Klein C, Kaletta C, Schnell N & Entian KD (1992) Analysis of genes involved in biosynthesis of the lantibiotic subtilin. Appl Environ Microbiol 58: 132-142.
128. Klein C, Kaletta C & Entian KD (1993) Biosynthesis of the lantibiotic subtilin is regulated by a histidine kinase/response regulator system. Appl Environ Microbiol 59: 296-303.
129. Kluskens LD, Kuipers A, Rink R, de Boef E, Fekken S, Driessen AJM, Kuipers OP & Moll GN (2005) Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin. Biochemistry 44: 12827-12834.
130. Koponen O, Tolonen M, Qiao M, Wahlström G, Helin J & Saris PEJ (2002) NisB is required for the dehydration and NisC for the lanthionine formation in the post-translational modification of nisin. Microbiology 148: 3561-3568.
131. Krull RE, Chen P, Novak J, Kirk M, Barnes S, Bakers J, Krishna NR & Caufield PW (2000) Biochemical structural analysis of the lantibiotic mutacin II. J Biol Chem 275: 15845-15850.
132. Kuipers OP, Rollema HS, Yap WMGJ, Boot HJ, Siezen RJ & de Vos WM (1992) Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J Biol Chem 267: 24340-24346.
133. Kuipers OP, Beerthuyzen MM, Siezen RJ & de Vos WM (1993) Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. Eur J Biochem 216: 281-291.
134. Kuipers OP, Beerthuyzen MM, de Ruyter PGGA, Luesink EJ & de Vos WM (1995) Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J Biol Chem 270: 27299-27304.
135. Kuipers OP, Bierbaum G, Ottenwälder B et al. (1996) Protein engineering of lantibiotics. Antonie Leeuwenhoek 69: 161-170.
136. Kuipers A, de Boef E, Rink R, Fekken S, Kluskens LD, Driessen AJM, Leenhouts K, Kuipers OP & Moll GN (2004) NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides. J Biol Chem 279: 22176-22182.
137. Kupke T & Götz F (1996) Expression, purification and characterization of EpiC, an enzyme involved in the biosynthesis of the lantibiotic epidermin, and sequence analysis of Staphylococcus epidermidis epiC mutants. J Bacteriol 178: 1335-1340.
138. Kupke T & Götz F (1997) The enethiolate anion reaction products of EpiD. pKa value of the enethiol side chain is lower than that of the thiol side chain of peptides. J Biol Chem 272: 4759-4762.
139. Kupke T, Kempter C, Gnau V, Jung G & Götz F (1994) Mass spectroscopic analysis of a novel enzymatic reaction. Oxidative decarboxylation of the lantibiotic precursor peptide EpiA catalyzed by the flavoprotein EpiD. J Biol Chem 269: 5653-5659.
140. Li B, Yu JPJ, Brunzelle JS, Moll GN, van der Donk WA & Nair SK (2006) Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis. Science 311: 1464-1467.
141. Lis M & Kuramitsu HK (2003) The stress-responsive dgk gene from Streptococcus mutans encodes a putative undecaprenol kinase activity. Infect Immun 71: 1938-1943.
142. Liu W & Hansen JN (1992) Enhancement of the chemical and antimicrobial properties of subtilin by site-directed mutagenesis. J Biol Chem 267: 25078-25085.
143. Madsen SM, Arnau J, Vrang A, Givskov M & Israelsen H (1999) Molecular characterization of the pH-inducible and growth phase-dependent promoter P170 of Lactococcus lactis. Mol Microbiol 32: 75-87.
144. Madsen SM, Hindré T, Le Pennec JP, Israelsen H & Dufour A (2005) Two acid-inducible promoters from Lactococcus lactis require the cis-acting ACiD-box and the transcription regulator RcfB. Mol Microbiol 56: 735-746.
145. Majer F, Schmid DG, Altena K, Bierbaum G & Kupke T (2002) The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin. J Bacteriol 184: 1234-1243.
146. Makino A, Baba T, Fujimoto K et al. (2003) Cinnamycin (Ro 09-0198) promotes cell binding and toxicity by inducing transbilayer lipid movement. J Biol Chem 278: 3204-3209.
147. Marcille F, Gomez A, Joubert P, Ladiré M, Veau G, Clara A, Gavini F, Willems A & Fons M (2002) Distribution of genes encoding the trypsin-dependent lantibiotic ruminococcin A among bacteria isolated from human fecal microbiota. Appl Environ Microbiol 68: 3424-3431.
148. Martin NI, Sprules T, Carpenter MR, Cotter PD, Hill C, Ross RP & Vederas JC (2004) Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry 43: 3049-3056.
149. McAuliffe O, Ryan MP, Ross RP, Hill C, Breeuwer P & Abee T (1998) Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl Environ Microbiol 64: 439-445.
150. McAuliffe O, Hill C & Ross RP (2000a) Each peptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity. Microbiology 146: 2147-2154.
151. McAuliffe O, Hill C & Ross RP (2000b) Identification and overexpression of ltnI, a novel gene which confers immunity to the two-component lantibiotic lacticin 3147. Microbiology 146: 129-138.
152. McAuliffe O, Ross RP & Hill C (2001a) Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol Rev 25: 285-308.
153. McAuliffe O, O'Keeffe T, Hill C & Ross RP (2001b) Regulation of immunity to the two-component lantibiotic, lacticin 3147, by the transcriptional repressor LtnR. Mol Microbiol 39: 982-993.
154. McLaughlin RE, Ferretti JJ & Hynes WL (1999) Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes. FEMS Microbiol Lett 175: 171-177.
155. Meyer C, Bierbaum G, Heidrich C, Reis M, Suling J, Iglesias-Wind MI, Kempter C, Molitor E & Sahl HG (1995) Nucleotide sequence of the lantibiotic Pep5 biosynthesis gene cluster and functional analysis of PepP and PepC: evidence for a role of PepC in thioether formation. Eur J Biochem 232: 478-489.
156. Miller LM, Chatterjee C, van der Donk WA & Kelleher NL (2006) The dehydratase activity of lacticin 481 synthetase is highly processive. J Am Chem Soc 128: 1420-1421.
157. Mills S, Coffey A, O'Sullivan L, Strokes D, Hill C, Fitzgerald GF & Ross RP (2002) Use of lacticin 481 to facilitate delivery of the bacteriophage resistance plasmid, pCBG104 to cheese starters. J Appl Microbiol 92: 238-246.
158. Mills S, McAuliffe OE, Coffey A, Fitzgerald GF & Ross RP (2006)
159. Minamikawa M, Kawai Y, Inoue N & Yamazaki K (2005) Purification and characterization of warnericin RB4, anti-Alicyclobacillus bacteriocin, produced by Staphylococcus warneri RB4. Curr Microbiol 51: 22-26.
160. Morgan SM, O'Connor PM, Cotter PD, Ross RP & Hill C (2005) Sequential actions of the two component peptides of the lantibiotic 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother 49: 2606-2611.
161. Nagao J, Aso Y, Sashihara T, Shioya K, Adachi A, Nakayama J & Sonomoto K (2005a) Localization and interaction of the biosynthetic proteins for the lantibiotic, nukacin ISK-1. Biosci Biotechnol Biochem 69: 1341-1347.
162. Nagao J, Harada Y, Shioya K, Aso Y, Zendo T, Nakayama J & Sonomoto K (2005b) Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli. Biochem Biophys Res Commun 336: 507-513.
163. Nakagawa I, Kurokawa K, Yamashita A et al. (2003) Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution. Genome Res 13: 1042-1055.
164. Nicolas G, Morency H, LaPointe G & Lavoie MC (2006) Mutacin H-29B is identical to mutacin II (J-T8). BMC Microbiol 6: 36.
165. Novák J, Caufield PW & Miller EJ (1994) Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans. J Bacteriol 176: 4316-4320.
166. O'Connor EM & Shand RF (2002) Halocins and sulfolobicins: the emerging story of archaeal protein and peptide antibiotics. J Ind Microbiol Biotechnol 28: 23-31.
167. Okeley NM, Paul M, Stasser JP, Blackburn N & van der Donk WA (2003) SpaC and NisC, the cyclases involved in subtilin and nisin biosynthesis, are zinc proteins. Biochemistry 42: 13613-13624.
168. Okuda K, Aso Y, Nagao J, Shioya K, Kanemasa Y, Nakayama J & Sonomoto K (2005) Characterization of functional domains of lantibiotic-binding immunity protein, NukH, from Staphylococcus warneri ISK-1. FEMS Microbiol Lett 250: 19-25.
169. O'Mahony T, Rekhif N, Cavadini C & Fitzgerald GF (2001) The application of a fermented food ingredient containing 'variacin', a novel antimicrobial produced by Kocuria varians, to control the growth of Bacillus cereus in chilled dairy products. J Appl Microbiol 90: 106-114.
170. O'Sullivan L, Morgan SM, Ross RP & Hill C (2002) Elevated enzyme release from lactococcal starter cultures on exposure to the lantibiotic lacticin 481, produced by Lactococcus lactis DPC5552. J Dairy Sci 85: 2130-2140.
171. O'Sullivan L, Ross RP & Hill C (2003a) A lacticin 481-producing adjunct cultures increases starter lysis while inhibiting non-starter lactic acid bacteria proliferation during Cheddar cheese ripening. J Appl Microbiol 95: 1235-1241.
172. O'Sullivan L, Ryan MP, Ross RP & Hill C (2003b) Generation of food-grade lactococcal starters which produce the lantibiotics lacticin 3147 and lacticin 481. Appl Environ Microbiol 69: 3681-3685.
173. Ottenwälder B, Kupke T, Brecht S, Gnau V, Metzger J, Jung G & Götz F (1995) Isolation and characterization of genetically engineered gallidermin and epidermin analogs. Appl Environ Microbiol 61: 3894-3903.
174. Otto M, Peschel A & Götz F (1998) Producer self-protection against the lantibiotic epidermin by the ABC transporter EpiFEG of Staphylococcus epidermidis Tu3298. FEMS Microbiol Lett 166: 203-211.
175. Oumer A, Garde S, Gaya P, Medina M & Nuñez M (2001) The effects of cultivating lactic starter cultures with bacteriocin-producing lactic acid bacteria. J Food Prot 64: 81-86.
176. Pag U, Heidrich C, Bierbaum G & Sahl HG (1999) Molecular analysis of expression of the lantibiotic Pep5 immunity phenotype. Appl Environ Microbiol 65: 591-598.
177. Papadelli M, Georgalaki M, Anastasiou R, Karsioti A & Tsakalidou E (2005) Sequencing of the macedocin biosynthesis regulon, a lantibiotic produced by Streptococcus macedonicus ACA-DC 198. 8th FEMS Symposium on Lactic Acid Bacteria. Genetics, Metabolism and Applications. Egmond aan Zee, The Netherlands.
178. Papadelli M, Karsioti A, Anastasiou R, Georgalaki M & Tsakalidou E (2006) Characterization of the gene cluster involved in the biosynthesis of macedocin, the lantibiotic produced by Streptococcus macedonicus. 7th ASM Conference on Streptococcal Genetics. Saint Malo, France.
179. Parrot M, Caufield PW & Lavoie MC (1990) Preliminary characterization of four bacteriocins from Streptococcus mutans. Can J Microbiol 36: 123-130.
180. Patton GC & van der Donk WA (2005) New developments in lantibiotic biosynthesis and mode of action. Curr Opin Microbiol 8: 543-551.
181. Peschel A & Götz F (1996) Analysis of the Staphylococcus epidermidis genes epiF, -E, and -G involved in epidermin immunity. J Bacteriol 178: 531-536.
182. Peschel A, Augustin J, Kupke T, Stevanovic S & Götz F (1993) Regulation of epidermin biosynthetic genes by EpiQ. Mol Microbiol 9: 31-39.
183. Peschel A, Schnell N, Hille M, Entian KD & Götz F (1997) Secretion of the lantibiotics epidermin and gallidermin: sequence analysis of the genes gdmT and gdmH, their influence on epidermin production and their regulation by EpiQ. Mol Gen Genet 254: 312-318.
184. Piard JC, Delorme C, Giraffa G, Commissaire J & Desmazeaud M (1990) Evidence for a bacteriocin produced by Lactococcus lactis CNRZ 481. Neth Milk Dairy J 44: 143-158.
185. Piard J-C, Muriana PM, Desmazeaud MJ & Klaenhammer TR (1992) Purification and partial characterization of lacticin 481, a lanthionine-containing bacteriocin produced by Lactococcus lactis subsp. lactis CNRZ 481. Appl Environ Microbiol 58: 279-284.
186. Piard J-C, Delorme C, Novel M, Desmazeaud M & Novel G (1993a) Conjugal transfer of the determinants for bacteriocin (lacticin 481) production and immunity in Lactococcus lactis subsp. lactis CNRZ 481. FEMS Microbiol Lett 112: 313-318.
187. Piard J-C, Kuipers OP, Rollema HS, Desmazeaud MJ & de Vos WM (1993b) Structure, organization, and expression of the lct gene for lacticin 481, a novel lantibiotic produced by Lactococcus lactis. J Biol Chem 268: 16361-16368.
188. Pillidge CJ, Collins LJ, Ward LJH, Cantillon BM, Shaw BD, Timmins MJ, Heap HA & Polzin KM (2000) Efficacy of four conjugal lactococcal phage resistance plasmids against phage in commercial Lactococcus lactis subsp. cremoris cheese starter strains. Int Dairy J 10: 617-625.
189. Pridmore D, Rekhif N, Pittet A-C, Suri B & Mollet B (1996) Variacin, a new lanthionine-containing bacteriocin produced by Micrococcus varians: comparison to lacticin 481 of Lactococcus lactis. Appl Environ Microbiol 62: 1799-1802.
190. Qi F, Chen P & Caufield PW (1999) Functional analyses of the promoters in the lantibiotic mutacin II biosynthetic locus in Streptococcus mutans. Appl Environ Microbiol 65: 652-658.
191. Qiao M, Immonen T, Koponen O & Saris PEJ (1995) The cellular location and effect on nisin immunity of the NisI protein from Lactococcus lactis N8 expressed in Escherichia coli and L. lactis. FEMS Microbiol Lett 131: 75-80.
192. Ramare F, Nicoli J, Dabard J, Corring T, Ladire M, Gueugneau AM & Raibaud P (1993) Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro. Appl Environ Microbiol 59: 2876-2883.
193. Rawlinson EL, Nes IF & Skaugen M (2002) LasX, a transcriptional regulator of the lactocin S biosynthetic genes in Lactobacillus sakei L45, acts both as an activator and a repressor. Biochimie 84: 559-567.
194. Rawlinson EL, Nes IF & Skaugen M (2005) Identification of the DNA-binding site of the Rgg-like regulator LasX within the lactocin S promoter region. Microbiology 151: 813-823.
195. Reis M, Eschbach-Bludau M, Iglesias-Wind MI, Kupke T & Sahl HG (1994) Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product. Appl Environ Microbiol 60: 2876-2883.
196. Rickard AH, Palmer RJ Jr, Blehert DS, Campagna SR, Semmelhack MF, Egland PG, Bassler BL & Kolenbrander PE (2006) Autoinducer 2: a concentration-dependent signal for mutualistic bacterial biofilm growth. Mol Microbiol 60: 1446-1456.
197. Riley MA & Wertz JE (2002) Bacteriocin diversity: ecological and evolutionary perspectives. Biochimie 84: 357-364.
198. Rincé A, Dufour A, Le Pogam S, Thuault D, Bourgeois CM & Le Pennec J-P (1994) Cloning, expression, and nucleotide sequence of genes involved in production of lactococcin DR, a bacteriocin from Lactococcus lactis subsp. lactis. Appl Environ Microbiol 60: 1652-1657.
199. Rincé A, Dufour A, Uguen P, Le Pennec J-P & Haras D (1997) Characterization of the lacticin 481 operon: the Lactococcus lactis genes lctF, lctE, and lctG encode a putative ABC transporter involved in bacteriocin immunity. Appl Environ Microbiol 63: 4252-4260.
200. Rink R, Kuipers A, de Boef E, Leenhouts KJ, Driessen AJM, Moll GN & Kuipers OP (2005) Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes. Biochemistry 44: 8873-8882.
201. Rodríguez E, González B, Gaya P, Nuñez M & Medina M (2000) Diversity of bacteriocins produced by lactic acid bacteria isolated from raw milk. Int Dairy J 10: 7-15.
202. Rodriguez E, Arques JL, Nuñez M, Gaya P & Medina M (2005) Combined effect of high-pressure treatments and bacteriocin-producing lactic acid bacteria on the inactivation of Escherichia coli O157:H7 in raw-milk cheese. Appl Environ Microbiol 71: 3399-3404.
203. Rollema HS, Kuipers OP, Both P, de Vos WM & Siezen RJ (1995) Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl Environ Microbiol 61: 2873-2878.
204. Ross KF, Ronson CW & Tagg JR (1993) Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl Environ Microbiol 59: 2014-2021.
205. Ross RP, Morgan S & Hill C (2002) Preservation and fermentation: past, present and future. Int J Food Microbiol 79: 3-16.
206. Ruhr E & Sahl HG (1985) Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob Agents Chemother 27: 841-845.
207. Rumpel S, Razeto A, Pillar CM, Vijayan V, Taylor A, Giller K, Gilmore MS, Becker S & Zweckstetter M (2004) Structure and DNA-binding properties of the cytolysin regulator CylR2 from Enterococcus faecalis. EMBO J 23: 3632-3642.
208. Ryan MP, Jack RW, Josten M, Sahl HG, Jung G, Ross RP & Hill C (1999) Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem 274: 37544-37550.
209. Sahl HG (1985) Influence of the staphylococcin-like peptide Pep5 on membrane potential of bacterial cells and cytoplasmic membrane vesicles. J Bacteriol 162: 833-836.
210. Sahl HG & Bierbaum G (1998) Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from Gram-positive bacteria. Annu Rev Microbiol 52: 41-79.
211. Sahl HG, Jack RW & Bierbaum G (1995) Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur J Biochem 230: 827-853.
212. Sashihara T, Kimura H, Higuchi T, Adachi A, Matsusaki H, Sonomoto K & Ishizaki A (2000) A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure. Biosci Biotechnol Biochem 64: 2420-2428.
213. Sashihara T, Dan M, Kimura H, Matsusaki H, Sonomoto K & Ishizaki A (2001) The effect of osmotic stress on the production of nukacin ISK-1 from Staphylococcus warneri ISK-1. Appl Microbiol Biotechnol 56: 496-501.
214. Schüller F, Benz R & Sahl HG (1989) The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes. Eur J Biochem 182: 181-186.
215. Schnell N, Entian KD, Schneider U, Götz F, Zahner H, Kellner R & Jung G (1988) Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333: 276-278.
216. Schnell N, Entian KD, Götz F, Hörner T, Kellner R & Jung G (1989) Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic. FEMS Microbiol Lett 58: 263-268.
217. Schnell N, Engelke G, Augustin J, Rosenstein R, Ungermann V, Götz F & Entian KD (1992) Analysis of genes involved in the biosynthesis of lantibiotic epidermin. Eur J Biochem 204: 57-58.
218. Segarra RA, Booth MC, Morales DA, Huycke MM & Gilmore MS (1991) Molecular characterization of the Enterococcus faecalis cytolysin activator. Infect Immun 59: 1239-1246.
219. Siegers K & Entian KD (1995) Genes involved in immunity to the lantibiotic nisin produced by Lactococcus lactis 6F3. Appl Environ Microbiol 61: 1082-1089.
220. Siegers K, Heinzmann S & Entian KD (1996) Biosynthesis of lantibiotic nisin. Post-translational modification of its prepeptide occurs at a multimeric membrane-associated lanthionine synthetase complex. J Biol Chem 271: 12294-12301.
221. Siezen RJ, Kuipers OP & de Vos WM (1996) Comparison of lantibiotic gene clusters and encoded proteins. Antonie Leeuwenhoek 69: 171-184.
222. Skaugen M, Nissen-Meyer J, Jung G, Stevanovic S, Sletten K, Abildgaard CIM & Nes IF (1994) In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide. J Biol Chem 269: 27183-27185.
223. Skaugen M, Abildgaard CIM & Nes IF (1997) Organization and expression of a gene cluster involved in the biosynthesis of the lantibiotic lactocin S. Mol Gen Genet 253: 674-686.
224. Skaugen M, Andersen EL, Christie VH & Nes IF (2002) Identification, characterization, and expression of a second, bicistronic, operon involved in the production of lactocin S in Lactobacillus sakei L45. Appl Environ Microbiol 68: 720-727.
225. Stein T & Entian KD (2002) Maturation of the lantibiotic subtilin: matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to monitor precursors and their proteolytic processing in crude bacterial cultures. Rapid Commun Mass Spectrom 16: 103-110.
226. Stein T, Borchert S, Kiesau P, Heinzmann S, Klöss S, Klein C, Helfrich M & Entian KD (2002) Dual control of subtilin biosynthesis and immunity in Bacillus subtilis. Mol Microbiol 44: 403-416.
227. Stein T, Heinzmann S, Solovieva I & Entian KD (2003) Function of Lactococcus lactis nisin immunity genes nisI and nisFEG after coordinated expression in the surrogate host Bacillus subtilis. J Biol Chem 278: 89-94.
228. Stein T, Heinzmann S, Düsterhus S, Borchert S & Entian KD (2005) Expression and functional analysis of the subtilin immunity genes spaIFEG in the subtilin-sensitive host Bacillus subtilis MO1099. J Bacteriol 187: 822-828.
229. Stock AM, Robinson VL & Goudreau PN (2000) Two-component signal transduction. Annu Rev Biochem 69: 183-215.
230. Sun J, Daniel R, Wagner-Dobler I & Zeng AP (2004) Is autoinducer-2 a universal signal for interspecies communication: a comparative genomic and phylogenic analysis of the synthesis and signal transduction pathways. BMC Evol Biol 4: 36.
231. Szekat C, Jack RW, Skutlarek D, Färber H & Bierbaum G (2003) Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin. Appl Environ Microbiol 69: 3777-3783.
232. Taga ME & Bassler BL (2003) Chemical communication among bacteria. Proc Natl Acad Sci USA 100(Suppl 2): 14549-14554.
233. Tagg JR (2004) Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocins-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Indian J Med Res 119(Suppl): 13-16.
234. Tagg JR, Read RSD & McGiven AR (1971) Bacteriocin production by group A streptococci. Pathology 3: 277-278.
235. Tagg JR, Read RSD & McGiven AR (1973) Bacteriocin of a group A streptococcus: partial purification and properties. Antimicrob Agents Chemother 4: 214-221.
236. Tagg JR, Dajani AS & Wannamaker LW (1976) Bacteriocins of Gram-positive bacteria. Bacteriol Rev 40: 722-756.
237. Tatusova TA & Madden TL (1999) Blast 2 sequences-a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 174: 247-250.
238. Thuault D, Beliard E, Le Guern J & Bourgeois C-M (1991) Inhibition of Clostridium tyrobutyricum by bacteriocin-like substances produced by lactic acid bacteria. J Dairy Sci 74: 1145-1150.
239. Turner DL, Brennan L, Meyer HE, Lohaus C, Siethoff C, Costa HS, Gonzalez B, Santos H & Suárez JE (1999) Solution structure of plantaricin C, a novel lantibiotic. Eur J Biochem 264: 833-839.
240. Twomey D, Ross RP, Ryan M, Meaney B & Hill C (2002) Lantibiotics produced by lactic acid bacteria: structure, function and applications. Antonie Leeuwenhoek 82: 165-185.
241. Uguen P, Hamelin J, Le Pennec J-P & Blanco C (1999) Influence of osmolarity and the presence of an osmoprotectant on Lactococcus lactis growth and bacteriocin production. Appl Environ Microbiol 65: 291-293.
242. Uguen P, Le Pennec J-P & Dufour A (2000) Lantibiotic biosynthesis: interactions between prelacticin 481 and its putative modification enzyme, LctM. J Bacteriol 182: 5262-5266.
243. Uguen P, Hindré T, Didelot S, Marty C, Haras D, Le Pennec J-P, Vallée-Réhel K & Dufour A (2005) Maturation by LctT is required for biosynthesis of full-length lantibiotic lacticin 481. Appl Environ Microbiol 71: 562-565.
244. Upton M, Tagg JR, Wescombe P & Jenkinson HF (2001) Intra-and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J Bacteriol 183: 3931-3938.
245. Van den Berghe E, Skourtas G, Tsakalidou E & De Vuyst L (2006) Streptococcus macedonicus ACA-DC 198 produces the lantibiotic, macedocin, at temperature and pH conditions that prevail during cheese manufacture. Int J Food Microbiol 107: 138-147.
246. van den Hooven HW, Lagerwerf FM, Heerma W, Haverkamp J, Piard J-C, Hilbers CW, Siezen RJ, Kuipers OP & Rollema HS (1996) The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges. FEBS Lett 391: 317-322.
247. van der Meer JR, Polman J, Beerthuyzen MM, Siezen RJ, Kuipers OP & de Vos WM (1993) Characterization of the Lactococcus lactis nisin A operon genes nisP, encoding a subtilisin-like serine protease involved in precursor processing, and nisR, encoding a regulatory protein involved in nisin biosynthesis. J Bacteriol 175: 2578-2588.
248. van Kraaij C, Breukink E, Rollema HS, Siezen RJ, Demel RA, De Kruijff B & Kuipers OP (1998) Pore formation by nisin involves translocation of its C-terminal part across the membrane. Biochemistry 37: 16033-16040.
249. Varcamonti M, Nicastro G, Venema G & Kok J (2001) Proteins of the lactococcin A secretion system: lcnD encodes two in-frame proteins. FEMS Microbiol Lett 204: 259-263.
250. Walls T, Power D & Tagg J (2003) Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J Med Microbiol 52: 829-833.
251. Wescombe PA & Tagg JR (2003) Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes. Appl Environ Microbiol 69: 2737-2747.
252. Wescombe PA, Burton JP, Cadieux PA, Klesse NA, Hyink O, Heng NCK, Chilcott CN, Reid G & Tagg JR (2006a) Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Leeuwenhoek 90: 269-280.
253. Wescombe PA, Upton M, Dierksen KP et al. (2006b) Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva. Appl Environ Microbiol 72: 1459-1466.
254. Widdick DA, Dodd HM, Barraille P, White J, Stein TH, Chater KF, Gasson MJ & Bibb MJ (2003) Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005. Proc Natl Acad Sci USA 100: 4316-4321.
255. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, de Kruijff B & Sahl HG (2001) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 276: 1772-1779.
256. Wiedemann I, Böttiger T, Bonelli RR et al. (2006a) The mode of action of the lantibiotic lacticin 3147 - a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol 61: 285-296.
257. Wiedemann I, Böttiger T, Bonelli RR, Schneider T, Sahl HG & Martínez B (2006b) Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl Environ Microbiol 72: 2809-2814.
258. Woodruff WA, Novak J & Caufield PW (1998) Sequence analysis of mutA and mutM genes involved in the biosynthesis of the lantibiotic mutacin II in Streptococcus mutans. Gene 206: 37-43.
259. Xie L & van der Donk WA (2004) Post-translational modifications during lantibiotic biosynthesis. Curr Opin Chem Biol 8: 498-507.
260. Xie L, Miller LM, Chatterjee C, Averin O, Kelleher NL & van der Donk WA (2004) Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity. Science 303: 679-681.
261. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.